HERON THERAPEUTICS, INC. /DE/ Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $4.64 per share as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2026-02-26
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.64.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $8.88.
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $12.87.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $17.86; Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price as first filed $19.13.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $4.64 10-K · filed 2026-02-26 | |
| 2024-12-31 | $8.88 10-K · filed 2025-02-27 | |
| 2023-12-31 | $12.87 10-K · filed 2024-03-12 | |
| 2021-12-31 | $17.86 10-K · filed 2023-03-29 | $19.13 10-K · filed 2022-02-28 |
| 2020-12-31 | $18.74 10-K · filed 2021-02-24 | |
| 2019-12-31 | $17.02 10-K · filed 2020-03-02 | |
| 2017-12-31 | $13.25 10-K · filed 2018-02-27 | |
| 2016-12-31 | $11.66 10-K · filed 2017-02-23 | |
| 2012-12-31 | $0.38 10-K · filed 2013-03-01 | |
| 2011-12-31 | $0.53 10-K · filed 2013-03-01 | |
| 2010-12-31 | $1.72 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |